Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 17 (RPL23AP17)
- Target
- RPL23AP17
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L23a pseudogene 17 (RPL23AP17) is a pseudogene related to the human ribosomal protein L23a gene.[2][3][4] Pseudogenes are non-functional segments of DNA similar to known genes, often resulting from gene duplication or retrotransposition, and do not encode functional proteins. RPL23AP17 is classified as a processed pseudogene, lacking known biological function, protein product, or involvement in disease. It is one of many ribosomal protein L23a pseudogenes dispersed throughout the human genome. There is currently no evidence that RPL23AP17 has a direct role as a therapeutic target, biomarker, or has known interactions with drugs.[2][3][4] Additional clarification: RPL23AP17 should not be confused with the functional gene *RPL23A*, which encodes the ribosomal subunit protein L23a. The pseudogene has no validated biological activity or therapeutic relevance in current literature.[2][3][4] Note: If you are looking for functional ribosomal protein targets or cancer biomarkers, references to *RPL23AP53* exist, but RPL23AP17 itself has no such data.[1]
- Other names
- RPL23A_3_37
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 17 (RPL23AP17).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 17 (RPL23AP17).